In our effort to fundamentally change the treatment paradigm for cancer care, it’s important to augment our skills and knowledge with a diverse advisory group that includes our board of directors, scientific leaders, and industry veterans.

This group’s contribution, along with the combined work of our internal team and our research consortium, is instrumental in making biology-guided radiotherapy a clinical reality.

Board of Directors

Scientific Advisory Board

Industry Advisory Board

David Auerbach

Co-founder of IMPAC (acquired by Elekta)

Morry Blumenfeld

Pioneer in medical imaging at GE Healthcare

Lester Boeh

Former VP of Emerging Businesses at Varian Medical Systems

Richard Schmidt, M.S.

Former Chief Engineer at TomoTherapy

George Zdaisuk

Former CTO of Varian Medical Systems